Episode
Episode 54, Part One: Michael Tolentino, MD, Co-Founder and Head Scientific Consultant, Aviceda Therapeutics
- Published
- May 28, 2025
- Duration seconds
- 2711
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/few-far-between-how-biotech-gets-built-4067896/episodes/episode-54-part-one-michael-tolentino-md-co-founder-and-head-scientific-consultant-aviceda-therapeutics/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/few-far-between-how-biotech-gets-built-4067896/episode-54-part-one-michael-tolentino-md-co-founder-and-head-scientific-consultant-aviceda-therapeutics.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
The challenge? Decoding the human immune system. Get ready to meet the top challenger on today's episode of the Biorasi Few & Far Between podcast. Host Chris O'Brien welcomes Michael Tolentino, MD, Co-Founder and Head Scientific Consultant at Aviceda Therapeutics, to the podcast. Tune in to part one of this special two-part episode as we explore Michael's start in ophthalmology, groundbreaking treatments in intra-retinal therapy, and the importance of being a great communicator. Okay, let's start the podcast!